The Patent Finder

Orega Biotech

Also on record
Records under this name other than the patents Orega Biotech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 4 of 4 · Back to Orega Biotech

PatentTitleStatus Expires Confidence
US 9,834,601Antagonists of IL-17 Isoforms and Their Uses
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,351,623Antagonists of IL-17 Isoforms and Their Uses
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,377,503Antibodies That Bind Human CD39 and Inhibit Atpase Activity of a Soluble Extracellular Domain Human CD39 Polypeptide
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,676,847IL-17 Antagonist Antibodies
Formerly held
Lapsed on the fee record
Ended Jun 13, 2025 · High confidence
Lapsed on the fee recordEnded Jun 13, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited